• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Acasti Pharma Inc. (ACST)

    -NasdaqCM
    0.33 Down 0.02(5.49%) Jul 2, 2:11PM EDT
    Add to Portfolio
    Prev Close:0.35
    Open:0.32
    Bid:0.16 x 3100
    Ask:1.00 x 10000
    1y Target Est:2.75
    Beta:1.33
    Next Earnings Date:N/A
    Day's Range:0.31 - 0.33
    52wk Range:0.28 - 1.22
    Volume:56,837
    Avg Vol (3m):83,281
    Market Cap:35.21M
    P/E (ttm):N/A
    EPS (ttm):-0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):169.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Feb-15) :-0.14
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment and prevention of various cardiometabolic disorders primarily abnormalities in blood lipids. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback